Back to Walleye Trading LLC Walleye Trading LLC

KNSAKNSA
4 quarters

Position history for Walleye Trading LLCWalleye Trading LLC's holdings in KINIKSA PHARMACEUTICALS-A

No. Walleye Trading exited its KNSA (Kiniksa Pharmaceuticals) position in Q1 2024. Its Q4 2023 13F listed 21,424 shares worth $375,777. Walleye Trading first reported KNSA in Q3 2022 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$202,000

Total Shares Change

-15,763

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%$19.73
0
2023-Q4
New
21,424
-
$375,7770.0%$17.54
33
2022-Q4
Exited
0
-100.0%
$00.0%$14.98
0
2022-Q3
New
15,763
-
$202,0000.0%$12.84
32

Other major holders of KNSA: BlackRock Finance, Inc., BAKER BROS. ADVISORS LP, HHLR ADVISORS, LTD.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used